László Attila, president of the Committee of Public Health of Romania, highlights the Committee’s efforts to mitigate the detrimental effects of Romania’s looming demographic crisis and medical “brain-drain”. Furthermore, he evaluates the country’s success in increasing the healthcare budget and emphasizes the importance of stable legislation.
Romania has the infrastructure and the people and has the potential to play a competitive role when it comes to clinical trials in Europe. Unfortunately, the capabilities are not being maximized
